Share
5,756 Posts.
lightbulb Created with Sketch. 308
clock Created with Sketch. 28/05/24
13:58
Share
Originally posted by Eagle0:
↑
I think the reasons given by Jon for halting the PW trial are genuine, but doing so does have a commercial advantage in my belief. He followed up those comments by saying if they can establish a new protocol for conducting future trials without onerous safety oversight because the safety of the drug has been proven, it should make future trials more streamlined and less onerous to conduct which is clearly beneficial for the asset holder and the patients. Theoretically, a new trial safety protocol might make it quicker to launch several Phase 2 trials on the back of a takeover in addition to moving forward the 3 current indications into Phase 3.
Expand
I presume, if they can renegotiate the safety aspect to be far less onerous with the FDA, it opens up an extremely efficient pathway to develop the entire pipeline of candidates.
(20min delay)